Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Un estudio de tucatinib con trastuzumab y mFOLFOX6 versus tratamiento estándar de atención en primera línea de cáncer colorrectal metastásico HER2+ (MOUNTAINEER-03)

19 de noviembre de 2026 actualizado por: Seagen, a wholly owned subsidiary of Pfizer

Un estudio abierto aleatorizado de fase 3 de tucatinib en combinación con trastuzumab y mFOLFOX6 versus mFOLFOX6 administrado con o sin cetuximab o bevacizumab como tratamiento de primera línea para sujetos con cáncer colorrectal metastásico HER2+

This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease.

Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable).

Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either:

  • mFOLFOX6 alone,
  • mFOLFOX6 with bevacizumab, or
  • mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Actual)

325

Fase

  • Fase 3

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Berlin, Alemania, 13353
        • Charité - Universitätsmedizin Berlin
      • Chemnitz, Alemania, 09116
        • Klinikum Chemnitz gGmbH
      • Dresden, Alemania, 01307
        • Technische Universität Dresden, Medizinische Fakultät Carl Gustav Carus
      • Dresden, Alemania, 01307
        • Gemeinschaftspraxis Hämatologie - Onkologie
      • Hamburg, Alemania, 22297
        • Hämatologisch Onkologische Praxis Eppendorf (HOPE)
      • Hamburg, Alemania, 22763
        • Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona
      • Hanover, Alemania, 30625
        • Medizinische Hochschule Hannover (MHH)
      • Ulm, Alemania, 89081
        • Universitaetsklinikum Ulm
    • Bavaria
      • Munich, Bavaria, Alemania, D-81675
        • CCC Muenchen TUM
    • Saxony
      • Leipzig, Saxony, Alemania, 04103
        • Universitätsklinikum Leipzig
      • Buenos Aires, Argentina, 1426
        • Instituto Medico Especializado Alexander Fleming
      • CABA, Argentina, 1280
        • Hospital Britanico de Buenos Aires
      • Córdoba, Argentina, X5001 HWE
        • IONC Instituto Oncologico de Cordoba Fundacion Richardet Longo
      • Córdoba, Argentina
        • CEMAIC - Centro Medico Privado
    • Buenos Aires
      • Pergamino, Buenos Aires, Argentina, 2700
        • Centro de Investigacion Pergamino SA
    • Santa Fe Province
      • Rosario, Santa Fe Province, Argentina, S2000DEJ
        • Instituto Medico de la Fundacion Estudios Clinicos
    • New South Wales
      • Camperdown, New South Wales, Australia, 2050
        • Chris O'Brien Lifehouse
    • Victoria
      • Fitzroy, Victoria, Australia, 3065
        • St Vincent's Hospital
      • São Paulo, Brasil, 01245-000
        • ICESP - Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira.
    • Paraná
      • Curitiba, Paraná, Brasil, 80810-050
        • CIONC-Centro Integrado de Oncologia de Curitiba
    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brasil, 91350-200
        • Centro Integrado de Pesquisa em Oncologia CIPO-GHC / Hospital Nossa Senhora da Conceicao
    • Rio de Janeiro
      • Barra da Tijuca, Rio de Janeiro, Brasil, 22.775-001
        • Instituto De Educação, Pesquisa e Gestão em Saúde - Instituto Américas
      • Rio de Janeiro, Rio de Janeiro, Brasil, 22775-001
        • Institute de Educacao, Pesquisa e Gestao em Saude - Instituto COI
      • Rio de Janeiro, Rio de Janeiro, Brasil, 22793-080
        • Institute de Educacao, Pesquisa e Gestao em Saude - Instituto COI
    • São Paulo
      • Barretos, São Paulo, Brasil, 14784-400
        • Hospital de Cancer de Barretos/Fundacao Pio XII
      • Jaú, São Paulo, Brasil, 17210-120
        • Centro de Pesquisas Clinicas da Fundação Doutor Amaral Carvalho
      • Santo André, São Paulo, Brasil, 09060-650
        • CEPHO - Centro de Estudos e Pesquisas de Hematologia e Oncologia.
      • São José do Rio Preto, São Paulo, Brasil, CEP 15090-000
        • Fundação Faculdade Regional de Medicina de São José do Rio Preto
      • Anderlecht, Bélgica, 1070
        • Institut Jules Bordet
      • Brussels, Bélgica, 1200
        • Cliniques Universitaires Saint-Luc
      • Edegem, Bélgica, 2650
        • UZA
      • Turnhout, Bélgica, 2300
        • Maag-,Darm- en Leverziekten AZ Turnhout
      • Turnhout, Bélgica, 2300
        • Oncologisch Dagziekenhuis AZ Turnhout Campus Sint-Elisabeth
    • Ontario
      • Ottawa, Ontario, Canadá, K1H 8L6
        • The Ottawa Hospital Cancer Centre
      • Toronto, Ontario, Canadá, M5G 1X5
        • Mount Sinai Hospital
      • Toronto, Ontario, Canadá, M4N 3M5
        • Sunnybrook Research Institute
    • Quebec
      • Montreal, Quebec, Canadá, H3T 1E2
        • Jewish General Hospital
    • Saskatchewan
      • Saskatoon, Saskatchewan, Canadá, S7N 4H4
        • Saskatoon Cancer Centre
      • Concepción, Chile
        • Biocenter
      • Santiago, Chile
        • Centro de estudios clinicos SAGA
    • Valparaiso
      • Viña del Mar, Valparaiso, Chile
        • Oncocentro Apys
      • Incheon, Corea del Sur, 21565
        • Gachon University Gil Medical Center
      • Seoul, Corea del Sur, 03080
        • Seoul National University Hospital
      • Seoul, Corea del Sur, 05505
        • Asan Medical Center
      • Seoul, Corea del Sur, 06351
        • Samsung Medical Center
      • Seoul, Corea del Sur, 03722
        • Severance Hospital, Yonsei University Health System
      • Seoul, Corea del Sur, 02841
        • Korea University Anam Hospital
      • Seoul, Corea del Sur, 08308
        • Korea University Guro Hospital
      • Bratislava, Eslovaquia, 833 10
        • Narodny Onkologicky ustav II.Onkologicka Klinika LFUK a NOU
      • Alicante, España, 03010
        • Hospital General Universitario de Alicante
      • Barcelona, España, 08036
        • Hospital Clinic de Barcelona
      • Barcelona, España, 08035
        • Hospital Vall d'Hebron
      • Barcelona, España, 08029
        • Radiology: CETIR Ascires
      • Córdoba, España, 14004
        • Hospital Universitario Reina Sofia
      • Lleida, España, 25198
        • Hospital Universitari Arnau de Vilanova
      • Madrid, España, 28034
        • Hospital Universitario Ramon y Cajal
      • Madrid, España, 28041
        • Hospital Universitario 12 de Octubre
      • Madrid, España, 28046
        • Hospital Universitario La Paz
      • Madrid, España, 28007
        • Hospital General Universitario Gregorio Maranon
      • Málaga, España, 29011
        • Hospital Regional Universitario de Malaga (Hospital Civil)
      • Ourense, España, 32005,
        • Complejo Hospitalario Universitario de Ourense
      • Oviedo, España, 33011
        • Hospital Universitario Central de Asturias
      • Pamplona, España, 31008
        • Complejo Hospitalario de Navarra
      • Santander, España, 39008
        • Hospital Universitario Marques de Valdecilla
      • Seville, España, 41013
        • Hospital Universitario Virgen del Rocio
      • Valencia, España, 46014
        • Hospital General Universitario de Valencia
      • Zaragoza, España, 50009
        • Hospital Universitario Miguel Servet
      • Zaragoza, España, 50006
        • Hospital Quiron Salud Zaragoza
    • Barcelona
      • L'Hospitalet de Llobregat, Barcelona, España, 08908
        • Hospital Duran i Reynals - Institut Catala d'Oncologia L'Hospitalet (ICO L'Hospitalet)
    • Other
      • Barcelona, Other, España, 08029
        • CETIR Viladomat
    • Santa CRUZ DE Tenerife
      • San Cristóbal de La Laguna, Santa CRUZ DE Tenerife, España, 38320
        • Complejo Hospitalario Universitario de Canarias
    • Arizona
      • Glendale, Arizona, Estados Unidos, 85304
        • Palo Verde Hematology Oncology
      • Phoenix, Arizona, Estados Unidos, 85054
        • Mayo Clinic Hospital
      • Phoenix, Arizona, Estados Unidos, 85054
        • Mayo Clinic Building - Phoenix
      • Scottsdale, Arizona, Estados Unidos, 85259
        • Mayo Clinic
    • California
      • Anaheim, California, Estados Unidos, 92801
        • Los Angeles Cancer Network - Anaheim
      • Anaheim, California, Estados Unidos, 92806
        • Kaiser Permanente Anaheim Kraemer Medical Offices
      • Baldwin Park, California, Estados Unidos, 91706
        • Kaiser Permanente Baldwin Park Medical Center
      • Bellflower, California, Estados Unidos, 90706
        • Kaiser Permanente Bellflower Medical Offices
      • Fontana, California, Estados Unidos, 92335
        • Kaiser Permanente Fontana Medical Center
      • Fountain Valley, California, Estados Unidos, 92708
        • Los Angeles Cancer Network - Fountain Vally
      • Glendale, California, Estados Unidos, 91204
        • Los Angeles Hematology Oncology Medical Group
      • Glendale, California, Estados Unidos, 91206
        • Los Angeles Hematology Oncology Medical Group
      • Glendale, California, Estados Unidos, 91204
        • Los Angeles Cancer Network - Corporate Office
      • Harbor City, California, Estados Unidos, 90710
        • Kaiser Permanente South Bay Medical center
      • Irvine, California, Estados Unidos, 92618
        • Kaiser Permanente Alton/Sand Canyon Medical Offices
      • Los Angeles, California, Estados Unidos, 90017
        • Los Angeles Hematology Oncology Medical Group
      • Los Angeles, California, Estados Unidos, 90033
        • USC/Norris Comprehensive Cancer Center
      • Los Angeles, California, Estados Unidos, 90033
        • Keck Hospital of USC
      • Los Angeles, California, Estados Unidos, 90033
        • Los Angeles General Medical Center
      • Los Angeles, California, Estados Unidos, 90034
        • Kaiser Permanente West Los Angeles Medical Center
      • Los Angeles, California, Estados Unidos, 90020
        • USC Norris Koreatown - Medical Oncology
      • Los Angeles, California, Estados Unidos, 90027
        • Kaiser Permanente Los Angeles Medical Offices
      • Newport Beach, California, Estados Unidos, 92663
        • USC Norris Oncology/Hematology - Newport Beach
      • Ontario, California, Estados Unidos, 91761
        • Kaiser Permanente Ontario Medical Center
      • Panorama City, California, Estados Unidos, 91402
        • Kaiser Permanente Panorama City Medical Center
      • Pasadena, California, Estados Unidos, 91105
        • Keck Medical Center of USC Pasadena
      • Pasadena, California, Estados Unidos, 91105
        • Los Angeles Hematology Oncology Medical Group
      • Riverside, California, Estados Unidos, 92505
        • Kaiser Permanente Riverside Medical Center
      • San Diego, California, Estados Unidos, 92108
        • Kaiser Permanente San Diego Mission Road (Regulatory and Lab Supplies)
      • San Diego, California, Estados Unidos, 92120
        • Kaiser Permanente Zion Medical Center
      • San Marcos, California, Estados Unidos, 92078
        • Kaiser Permanente San Marcos Medical Offices
      • Van Nuys, California, Estados Unidos, 91405
        • Los Angeles Hematology Oncology Medical Group
      • Woodland Hills, California, Estados Unidos, 91367
        • Kaiser Permanente Woodland Hills Medical Center
    • Colorado
      • Aurora, Colorado, Estados Unidos, 80012
        • Rocky Mountain Cancer Centers, LLP
      • Boulder, Colorado, Estados Unidos, 80303
        • Rocky Mountain Cancer Centers, LLP
      • Colorado Springs, Colorado, Estados Unidos, 80907
        • Rocky Mountain Cancer Centers, LLP
      • Denver, Colorado, Estados Unidos, 80218
        • Rocky Mountain Cancer Centers, LLP
      • Denver, Colorado, Estados Unidos, 80220
        • Rocky Mountain Cancer Centers, LLP
      • Lakewood, Colorado, Estados Unidos, 80228
        • Rocky Mountain Cancer Centers, LLP
      • Littleton, Colorado, Estados Unidos, 80120
        • Rocky Mountain Cancer Centers, LLP
      • Lone Tree, Colorado, Estados Unidos, 80124
        • Rocky Mountain Cancer Centers, LLP
      • Longmont, Colorado, Estados Unidos, 80504
        • Rocky Mountain Cancer Centers, LLP
      • Pueblo, Colorado, Estados Unidos, 81003
        • Rocky Mountain Cancer Centers, LLP
      • Thornton, Colorado, Estados Unidos, 80260
        • Rocky Mountain Cancer Centers, LLP
    • Florida
      • Aventura, Florida, Estados Unidos, 33180
        • Mount Sinai Medical Center Aventura ER
      • Miami Beach, Florida, Estados Unidos, 33140
        • Mount Sinai Medical Center
      • Miami Beach, Florida, Estados Unidos, 33140
        • Mount Sinai Braman Comprehensive Cancer Center
    • Georgia
      • Atlanta, Georgia, Estados Unidos, 30322
        • Emory University Hospital
      • Atlanta, Georgia, Estados Unidos, 30308
        • Emory University Hospital Midtown
      • Atlanta, Georgia, Estados Unidos, 30342
        • Emory Saint Joseph's Hospital
      • Atlanta, Georgia, Estados Unidos, 30322
        • Winship Cancer Institute
    • Kansas
      • Merriam, Kansas, Estados Unidos, 66204
        • Alliance for Multispecialty Research LLC.
    • Kentucky
      • Louisville, Kentucky, Estados Unidos, 40202
        • Norton Hospital
      • Louisville, Kentucky, Estados Unidos, 40217
        • Norton Cancer Institute, Audubon Hospital Campus
      • Louisville, Kentucky, Estados Unidos, 40241
        • Norton Brownsboro Hospital
      • Louisville, Kentucky, Estados Unidos, 40241
        • Norton Cancer Institute, Brownsboro Hospital Campus
      • Louisville, Kentucky, Estados Unidos, 40202
        • Norton Cancer Institute, Downtown
      • Louisville, Kentucky, Estados Unidos, 40217
        • Norton Audubon Hospital
      • Louisville, Kentucky, Estados Unidos, 40202
        • Norton Cancer Institute - Downtown
    • Minnesota
      • Burnsville, Minnesota, Estados Unidos, 55337
        • Minnesota Oncology Hematology, PA
      • Coon Rapids, Minnesota, Estados Unidos, 55433
        • Minnesota Oncology Hematology, PA
      • Coon Rapids, Minnesota, Estados Unidos, 55433
        • Allina Health Cancer institute
      • Edina, Minnesota, Estados Unidos, 55435
        • Minnesota Oncology Hematology, PA
      • Edina, Minnesota, Estados Unidos, 55435
        • M Health Fairview Cancer Clinic-Edina
      • Maple Grove, Minnesota, Estados Unidos, 55369
        • Minnesota Oncology Hematology, PA
      • Maplewood, Minnesota, Estados Unidos, 55109
        • M Health Fairview St. John's Hospital
      • Maplewood, Minnesota, Estados Unidos, 55109
        • Minnesota Oncology Hematology, PA
      • Minneapolis, Minnesota, Estados Unidos, 55415
        • Hennepin County Medical Center
      • Minneapolis, Minnesota, Estados Unidos, 55404
        • Allina Health Cancer Institute (Virginia Piper Cancer Institute)
      • Robbinsdale, Minnesota, Estados Unidos, 55422
        • North Memorial Health Cancer Center
      • Rochester, Minnesota, Estados Unidos, 55905
        • Mayo Clinic Cancer Center Outpatient Pharmacy
      • Saint Louis Park, Minnesota, Estados Unidos, 55426
        • Park Nicollet Frauenshuh Cancer Center
      • Saint Louis Park, Minnesota, Estados Unidos, 55416
        • Metro Minnesota Community Oncology Research Consortium
      • Saint Louis Park, Minnesota, Estados Unidos, 55426
        • Regulatory Location: MMCORC
      • Saint Paul, Minnesota, Estados Unidos, 55101
        • Regions Hospital
      • Saint Paul, Minnesota, Estados Unidos, 55102
        • Allina Health Cancer Institute-United(VPCI)
      • Waconia, Minnesota, Estados Unidos, 55387
        • Minnesota Oncology & Ridgeview Cancer & Infusion Center
      • Woodbury, Minnesota, Estados Unidos, 55125
        • Minnesota Oncology Hematology, PA Cornerstone Medical Specialty Center
    • New Jersey
      • Basking Ridge, New Jersey, Estados Unidos, 07920
        • MSK Basking Ridge
      • Middletown, New Jersey, Estados Unidos, 07748
        • MSK Monmouth
      • Montvale, New Jersey, Estados Unidos, 07645
        • MSK Bergen
    • New York
      • Commack, New York, Estados Unidos, 11725
        • MSK Commack
      • Harrison, New York, Estados Unidos, 10604
        • MSK Westchester
      • New York, New York, Estados Unidos, 10065
        • Memorial Sloan Kettering Cancer Center - Main Campus
      • New York, New York, Estados Unidos, 10022
        • Rockefeller Outpatient Pavilion (53rd Street)
      • Uniondale, New York, Estados Unidos, 11553
        • MSK Nassau
    • North Carolina
      • Durham, North Carolina, Estados Unidos, 27710
        • Duke University Medical Center
      • Durham, North Carolina, Estados Unidos, 27710
        • Duke University Hospital
      • Durham, North Carolina, Estados Unidos, 27710
        • Duke University Medical Center, Duke Cancer Center
      • Pinehurst, North Carolina, Estados Unidos, 28374
        • FirstHealth Cancer Center
      • Pinehurst, North Carolina, Estados Unidos, 28374
        • FirstHealth Moore Regional Hospital
    • Ohio
      • Canton, Ohio, Estados Unidos, 44718
        • Gabrail Cancer Center Research
    • Oregon
      • Happy Valley, Oregon, Estados Unidos, 97015
        • Northwest Cancer Specialists, P.C
      • Portland, Oregon, Estados Unidos, 97213
        • Providence Cancer Institute Franz Clinic
      • Portland, Oregon, Estados Unidos, 97213
        • Providence Portland Medical Center
      • Portland, Oregon, Estados Unidos, 97227
        • Northwest Cancer Specialists, P.C.
      • Portland, Oregon, Estados Unidos, 97225
        • Providence St. Vincent Medical Center
      • Portland, Oregon, Estados Unidos, 97225
        • Providence Oncology and Hematology Care Clinic - Westside
      • Tigard, Oregon, Estados Unidos, 97223
        • Northwest Cancer Specialists, P.C.
    • Pennsylvania
      • Beaver, Pennsylvania, Estados Unidos, 15009
        • UPMC Hillman Cancer Center - Beaver
      • Butler, Pennsylvania, Estados Unidos, 16001
        • UPMC Hillman Cancer Center at Butler Health System
      • Erie, Pennsylvania, Estados Unidos, 16505
        • UPMC Hillman Cancer Center Erie
      • Greensburg, Pennsylvania, Estados Unidos, 15601
        • UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health
      • Harrisburg, Pennsylvania, Estados Unidos, 17109
        • UPMC Hillman Cancer Center - Pinnacle (Community Osteopathic / Medical Sciences Pavillion)
      • Irwin, Pennsylvania, Estados Unidos, 15642
        • UPMC Hillman Cancer Center at Arnold Palmer Pavilion, In Partnership with Excela Health
      • Mechanicsburg, Pennsylvania, Estados Unidos, 17050
        • UPMC Hillman Cancer Center - Pinnacle (Ortenzio)
      • Monroeville, Pennsylvania, Estados Unidos, 15146
        • UPMC Hillman Cancer Center - Monroeville
      • Pittsburgh, Pennsylvania, Estados Unidos, 15232
        • UPMC Hillman Cancer Center
      • Pittsburgh, Pennsylvania, Estados Unidos, 15237
        • UPMC Hillman Cancer Center - Passavant (HOA)
      • Pittsburgh, Pennsylvania, Estados Unidos, 15215
        • UPMC Hillman Cancer Center - St Margarets
      • Pittsburgh, Pennsylvania, Estados Unidos, 15243
        • St. Clair Cancer Center Medical Oncology
    • South Dakota
      • Sioux Falls, South Dakota, Estados Unidos, 57105
        • Avera Cancer Institute
    • Tennessee
      • Nashville, Tennessee, Estados Unidos, 37232
        • Henry-Joyce Cancer Clinic
    • Texas
      • Arlington, Texas, Estados Unidos, 76012
        • Texas Oncology - DFW
      • Arlington, Texas, Estados Unidos, 76014
        • Texas Oncology - DFW
      • Bedford, Texas, Estados Unidos, 76022
        • Texas Oncology - DFW
      • Dallas, Texas, Estados Unidos, 75246
        • Texas Oncology - DFW
      • Dallas, Texas, Estados Unidos, 75231
        • Texas Oncology - DFW
      • Dallas, Texas, Estados Unidos, 75203
        • Texas Oncology - DFW
      • Dallas, Texas, Estados Unidos, 75230
        • Texas Oncology - DFW
      • Dallas, Texas, Estados Unidos, 75237
        • Texas Oncology - DFW
      • Fort Worth, Texas, Estados Unidos, 76104
        • Texas Oncology - DFW
      • Grapevine, Texas, Estados Unidos, 76051
        • Texas Oncology - DFW
      • Houston, Texas, Estados Unidos, 77030
        • The University of Texas MD Anderson Cancer Center
      • Plano, Texas, Estados Unidos, 75075
        • Texas Oncology - DFW
      • Plano, Texas, Estados Unidos, 75093
        • Texas Oncology - DFW
    • Virginia
      • Blacksburg, Virginia, Estados Unidos, 24060
        • Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care
      • Low Moor, Virginia, Estados Unidos, 24457
        • Oncology & Hematology Associates of Southwest Virginia
      • Roanoke, Virginia, Estados Unidos, 24014
        • Oncology & Hematology Associates of Southwest Virginia Inc dba Blue Ridge Cancer Care
      • Salem, Virginia, Estados Unidos, 24153
        • Oncology & Hematology Associates of Southwest Virginia, Inc. D.B.A Blue Ridge Cancer Care
      • Wytheville, Virginia, Estados Unidos, 24382
        • Oncology & Hematology Associates of Southwest Virginia
    • Washington
      • Vancouver, Washington, Estados Unidos, 98684
        • Northwest Cancer Specialists, P.C.
      • Brest, Francia, 29200
        • CHU Brest Hopital Cavale Blanche
      • Clermont-Ferrand, Francia, 63100
        • CHU Estaing
      • Créteil, Francia, 94000
        • Hopital Henri Mondor
      • Dijon, Francia, 21079
        • Center Georges-Francois Leclerc
      • Lyon, Francia, 69437
        • Hopital Edouard Herriot
      • Marseille, Francia, 13285
        • Höpital Saint-Joseph
      • Nice, Francia, 06189
        • Centre Antoine Lacassagne
      • Paris, Francia, 75012
        • Hopital Saint-Antoine
      • Paris, Francia, 75015
        • Hopital Europeen Georges Pompidou
      • Poitiers, Francia, 86000
        • CHU Poitiers
      • Rouen, Francia, 76031
        • CHU de Rouen
      • Saint-Herblain, Francia, 44805 Cedex
        • Institut de Cancérologie de l'Ouest - Saint-Herblain
      • Saint-Priest-en-Jarez, Francia, 42270
        • Centre Hospitalier Universitaire Sainte-Etienne - Hopital Nord
      • Strasbourg, Francia, 67033
        • Institut de Cancerologie Strasbourg Europe
      • Toulouse, Francia, 31059
        • CHU Toulouse-Rangueil
    • Other
      • Besançon, Other, Francia, 25000
        • Centre Hospitalier Regional et Universitaire de Besancon - Hopital Jean-Minjoz
      • Athens, Grecia, 11528
        • Evgenidion Clinic Agia Trias Oncology Department
    • Attikí
      • Athens, Attikí, Grecia, 11525
        • Athens Medical Center - Psychikon branch
    • Chaidari
      • Athens, Chaidari, Grecia, 124 62
        • University General Hospital "Attikon"
    • Thessaloniki
      • Nea Efkarpia, Thessaloniki, Grecia, 56403
        • "Papageorgiou" General Hospital of Thessaloniki 2nd Internal Medicine/Oncology Clinic of Aristotle
      • Cork, Irlanda, T12 DV56
        • Bon Secours Hospital
      • Cork, Irlanda, T12 DC4A
        • Cork University Hospital,Department of Medical Onncology
      • Dublin, Irlanda, D07 R2WY
        • Mater Misericordiae University Hospital
      • Dublin, Irlanda, D07 WKW8
        • Mater Private Hospital
      • Dublin, Irlanda, D09 V2N0
        • Beaumont Hospital
      • Dublin, Irlanda, D04 T6F4
        • St Vincents University Hospital
      • Waterford, Irlanda, X91 ER8E
        • University Hospital Waterford
      • Foggia, Italia, 71122
        • Struttura Semplice Dipartimentale di Oncologia Medica e Terapia Biomolecolare Azienda Ospedaliero
      • Pavia, Italia, 27100
        • Fondazione IRCCS Policlinico San Matteo
      • Reggio Emilia, Italia, 42123
        • S.C Oncologia Arcispedale Santa Maria Nuova
      • Sondrio, Italia, 23100
        • ASST della Valtellina e dell'alto Lario - Presidio Ospedaliero di Sondrio
    • Cagliari
      • Monserrato, Cagliari, Italia, 09042
        • Azienda Ospedaliera Universitaria Cagliari
    • Campania
      • Avellino, Campania, Italia, 83100
        • UOC Oncologia Medica - Dipartimento Onco Ematologico AORN San Giuseppe Moscati di Avellino
    • Genoa
      • Genova, Genoa, Italia, 16132
        • IRCCS Azienda Ospedaliera Metropolitana (IRCCS AOM)
    • Lazio
      • Rome, Lazio, Italia, 00168
        • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    • Lecce
      • Tricase, Lecce, Italia, 73039
        • UOC Oncologia, Azienda Ospedaliera Cardinale Giovanni Panico
    • Lombardy
      • Brescia, Lombardy, Italia, 25124
        • Fondazione Poliambulanza Istituto Ospedaliero
      • Milan, Lombardy, Italia, 20133
        • Fondazione IRCCS Istituto Nazionale dei Tumori
      • Milan, Lombardy, Italia, 20141
        • lstituto Europeo di Oncologia
      • Milan, Lombardy, Italia, 20162
        • Niguarda Cancer Center Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda
    • Naples
      • Naples, Naples, Italia, 80131
        • Azienda Ospedaliera Universitaria Luigi Vanvitelli
    • Tuscany
      • Florence, Tuscany, Italia, 50134
        • SODc Oncologia Medica e Clinica, AOU Careggi
      • Pisa, Tuscany, Italia, 56126
        • Azienda Ospedaliero Universitaria Pisana
    • Veneto
      • Padova, Veneto, Italia, 35128
        • Istituto Oncologico Veneto - IRCCS
      • Osaka, Japón, 540-0006
        • National Hospital Organization Osaka National Hospital
    • Chiba
      • Chiba, Chiba, Japón, 260-8717
        • Chiba Cancer Center
      • Kashiwa-shi, Chiba, Japón, 277-8577
        • National Cancer Center Hospital East
    • Ehime
      • Matsuyama, Ehime, Japón, 791-0280
        • NHO Shikoku Cancer Center
    • Fukuoka
      • Fukuoka, Fukuoka, Japón, 811-1395
        • National Hospital Organization Kyushu Cancer Center
    • Hokkaido
      • Sapporo, Hokkaido, Japón, 060-8648
        • Hokkaido University Hospital
    • Kagawa-ken
      • Kita-gun, Kagawa-ken, Japón, 761-0793
        • Kagawa University Hospital
    • Kanagawa
      • Kawasaki-shi, Kanagawa, Japón, 216-8511
        • St. Marianna University Hospital
      • Yokohama, Kanagawa, Japón, 241-8515
        • Kanagawa Cancer Center
    • Osaka
      • Osaka, Osaka, Japón, 558-8558
        • Osaka General Medical Center
      • Osakasayama-shi, Osaka, Japón, 589-8511
        • Kindai University Hospital
      • Sakai, Osaka, Japón, 590-0197
        • Kindai University Hospital
      • Suita, Osaka, Japón, 565-0871
        • The University of Osaka Hospital
      • Takatsuki-shi, Osaka, Japón, 569-8686
        • Osaka Medical and Pharmaceutical University Hospital
    • Saitama
      • Kitaadachi-gun, Saitama, Japón, 362-0806
        • Saitama Cancer Center
    • Tokyo
      • Chuo-Ku, Tokyo, Japón, 104-0045
        • National Cancer Center Hospital
      • Koto-ku, Tokyo, Japón, 135-8550
        • Cancer Institute Hospital of JFCR
      • Oslo, Noruega, 0379
        • Oslo University Hospital (OUH) - The Norwegian Radium Hospital
      • Amsterdam, Países Bajos, 1066 CX
        • Netherlands Cancer Institute
      • Utrecht, Países Bajos, 3543 AZ
        • St. Antonius Ziekenhuis - Ziekenhuis Utrecht
      • Venlo, Países Bajos, 5912 BL
        • Viecuri Medisch Centrum
      • Lodz, Polonia, 91-211
        • Salve Medica
    • Greater Poland Voivodeship
      • Konin, Greater Poland Voivodeship, Polonia, 62-500
        • Przychodnia Lekarska KOMED Roman Karaszewski
    • Masovian Voivodeship
      • Warsaw, Masovian Voivodeship, Polonia, 02-034
        • Narodowy lnstytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy lnstytut Badawczy
    • Pomeranian Voivodeship
      • Gdansk, Pomeranian Voivodeship, Polonia, 80-214
        • Klinika Onkologii i Radioterapii Uniwersyteckie Centrum Kliniczne.
      • Beijing, Porcelana, 100142
        • Beijing Cancer Hospital
      • Changsha, Porcelana, 410013
        • Hunan Cancer Hospital
      • Chongqing, Porcelana, 400042
        • Army Specialty Medical Center of The Chinese People's Liberation Army
      • Shanghai, Porcelana, 201620
        • Shanghai General Hospital
    • Fujian
      • Fuzhou, Fujian, Porcelana, 350001
        • Fujian Medical University Union Hospital
    • Gansu
      • Lanzhou, Gansu, Porcelana, 730000
        • The First Hospital of Lanzhou University
    • Guangdong
      • Guangzhou, Guangdong, Porcelana, 510655
        • The Sixth Affiliated hospital, Sun Yat-sen University
      • Meizhou, Guangdong, Porcelana, 514031
        • Meizhou People's hospital
    • Hainan
      • Haikou, Hainan, Porcelana, 570216
        • The Second Affiliated Hospital of Hainan Medical University
    • Hebei
      • Chengde, Hebei, Porcelana, 067000
        • Affiliated Hospital of Chengde Medical University
      • Chengde, Hebei, Porcelana, 067055
        • Affiliated Hospital of Chengde Medical University
      • Tangshan, Hebei, Porcelana, 063001
        • Tangshan People's Hospital
    • Heilongjiang
      • Harbin, Heilongjiang, Porcelana, 150081
        • Harbin Medical University Cancer Hospital
    • Henan
      • Nanyang, Henan, Porcelana, 473009
        • Nanyang Second General Hospital
      • Zhengzhou, Henan, Porcelana, 450003
        • Henan Provincial People's Hospital
    • Hubei
      • Wuhan, Hubei, Porcelana, 430079
        • Hubei Cancer Hospital
    • Hunan
      • Changsha, Hunan, Porcelana, 410011
        • The Second Xiangya Hospital of Central South University
    • Jiangsu
      • Changzhou, Jiangsu, Porcelana, 213003
        • The First People's Hospital of Changzhou
      • Suzhou, Jiangsu, Porcelana, 215031
        • The First Affiliated Hospital of Suzhou University
      • Xuzhou, Jiangsu, Porcelana, 221009
        • Xuzhou Central Hospital
    • Jiangxi
      • Nanchang, Jiangxi, Porcelana, 330006
        • The First Affiliated Hospital of Nanchang University
    • Liaoning
      • Jinzhou, Liaoning, Porcelana, 121001
        • The First Affiliated Hospital of Jinzhou Medical University
      • Shenyang, Liaoning, Porcelana, 110042
        • Liaoning Cancer Hospital & Institute
    • Shandong
      • Jinan, Shandong, Porcelana, 250013
        • Jinan Central Hospital
      • Jinan, Shandong, Porcelana, 250117
        • Shandong Cancer Hospital
      • Linyi, Shandong, Porcelana, 276034
        • LinYi Cancer Hospital
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Porcelana, 200092
        • Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
    • Shanxi
      • Taiyuan, Shanxi, Porcelana, 030013
        • Shanxi Province Cancer Hospital
    • Zhejiang
      • Hangzhou, Zhejiang, Porcelana, 310009
        • The Second Affiliated Hospital of Zhejiang University School of Medicine
      • Hangzhou, Zhejiang, Porcelana, 310016
        • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
      • Almada, Portugal, 2805-267
        • Hospital Garcia de Orta
      • Guarda, Portugal, 6300-035
        • Unidade Local de Saude da Guarda-Hospital Sousa Martins
      • Lisbon, Portugal, 1400-038
        • Fundacao Champalimaud
      • Porto, Portugal, 4099-001
        • Centro Hospitalar Universitário de Santo Antonio,E.P.E.
      • Leeds, Reino Unido, LS97TF
        • Leeds Teaching Hospitals NHS Trust, st James's Institute of Oncology
      • London, Reino Unido, W12 0NN
        • Imperial College Healthcare NHS Trust
      • London, Reino Unido, SW3 6JJ
        • The Royal Marsden Hospital - Chelsea Site
      • Manchester, Reino Unido, M20 4BX
        • The Christie NHS Foundation Trust
    • Chelsea
      • Newcastle upon Tyne, Chelsea, Reino Unido, NE7 7DN
        • The Newcastle upon Tyne Hospitals NHS Foundation Trust
    • England
      • Cambridge, England, Reino Unido, CB2 0QQ
        • Cambridge University Hospitals NHS Foundation Trust, Oncology Centre
    • Surrey
      • Sutton, Surrey, Reino Unido, SM2 5PT
        • The Royal Marsden Hospital
      • Zurich, Suiza, 8091
        • Universitatsspital Zurich - Klinik fur Medizinische Onkologie und Hamatologie USZ
      • Kaohsiung City, Taiwán, 833, (R.O.C.)
        • Kaohsiung Chang Gung Memorial Hospital
      • Tainan, Taiwán, 704, R.O.C.
        • National Cheng Kung University Hospital
      • Taipei, Taiwán, 11217
        • Taipei Veterans General Hospital
      • Taipei, Taiwán, 100 ROC
        • National Taiwan University Hospital
      • Taoyuan, Taiwán, 333 (R.O.C.)
        • Chang Gung Memorial Hospital LinKou

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Histologically and/or cytologically confirmed adenocarcinoma of the colon or rectum which is locally advanced unresectable or metastatic

  • Able to provide the most recently available formalin-fixed paraffin-embedded (FFPE) tumor tissue blocks (or freshly sectioned slides) obtained prior to treatment initiation to a central laboratory

    • If archival tissue is not available, a newly-obtained baseline biopsy of an accessible tumor lesion is required within 35 days prior to start of study treatment
  • HER2+ disease as determined by a tissue based assay performed at a central laboratory.

  • Participant has rat sarcoma viral oncogene homolog wild-type (RAS WT) disease as determined by local or central testing. For central RAS analysis, tissue sample must be analyzed within 1 year of biopsy date.

  • Radiographically measurable disease per RECIST v1.1 with:

    • At least one site of disease that is measurable and that has not been previously irradiated, or
    • If the participant has had previous radiation to the target lesion(s), there must be evidence of progression since the radiation
  • Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1

  • CNS Inclusion - based on contrast brain magnetic resonance imaging, participants may have any of the following:

    • No evidence of brain metastases
    • Previously treated brain metastases which are asymptomatic

Exclusion Criteria:

  • Prior systemic anticancer therapy for colorectal cancer (CRC) in the locally advanced unresectable or metastatic setting; note that participants may have received a maximum of 2 doses of mFOLFOX6 in the locally advanced/unresectable or metastatic setting prior to randomization.

    • Note: May have received chemotherapy for CRC in the adjuvant setting if it was completed >6 months prior to enrollment
  • Radiation therapy within 14 days prior to enrollment (or within 7 days in the setting of stereotactic radiosurgery)

  • Previous treatment with anti-HER2 therapy

  • Ongoing Grade 3 or higher neuropathy

  • Active or untreated gastrointestinal (GI) perforation at the time of screening.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Tucatinib Arm

Tucatinib + trastuzumab + mFOLFOX6

300mg given by mouth (orally) twice daily

Otros nombres:
  • TUKYSA, ONT-380, ARRY-380, PF-07265792

8mg/kg loading dose will be given into the vein (IV; intravenously) on Cycle 1 day 1, followed by 6mg/kg given by IV every 3 weeks thereafter.

Otros nombres:
  • Herceptina

85mg/m2 given by IV every 2 weeks. Component of mFOLFOX6.

400mg/ m2 given by IV every 2 weeks. Component of mFOLFOX6.

200mg/ m2 given by IV every 2 weeks. May be given in place of leucovorin. Component of mFOLFOX6.

400mg/m2 given by IV bolus then 2400mg/m2 given by continuous IV infusion (over 46-48 hours) every 2 weeks. Component of mFOLFOX6.

Comparador activo: Standard of Care Arm

Either (1) mFOLFOX6, (2) mFOLFOX6 and bevacizumab, or (3) mFOLFOX6 and cetuximab

85mg/m2 given by IV every 2 weeks. Component of mFOLFOX6.

400mg/ m2 given by IV every 2 weeks. Component of mFOLFOX6.

200mg/ m2 given by IV every 2 weeks. May be given in place of leucovorin. Component of mFOLFOX6.

400mg/m2 given by IV bolus then 2400mg/m2 given by continuous IV infusion (over 46-48 hours) every 2 weeks. Component of mFOLFOX6.

5mg/kg given by IV every 2 weeks

Otros nombres:
  • Avastin

400mg/m2 loading dose will be given by IV on Cycle 1 day 1, followed by 250mg/m2 given by IV weekly

Otros nombres:
  • Erbitux

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v1.1) by Blinded Independent Central Review (BICR)
Periodo de tiempo: Up to approximately 3 years

The time from the date of randomization to the BICR assessment of disease progression according to RECIST v1.1 or death from any cause

Up to approximately 3 years

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Incidencia de alteraciones de dosis
Periodo de tiempo: Hasta 30 días después del último tratamiento del estudio; aproximadamente 1 año
Hasta 30 días después del último tratamiento del estudio; aproximadamente 1 año
Overall survival (OS)
Periodo de tiempo: Up to approximately 6 years

The time from randomization to death from any cause

Up to approximately 6 years
Confirmed objective response rate (cORR) per RECIST v1.1 by BICR
Periodo de tiempo: Up to approximately 3 years

The proportion of participants with confirmed complete response (CR) or partial response (PR) according to RECIST v1.1, as assessed by BICR

Up to approximately 3 years
PFS per RECIST v1.1 by investigator assessment
Periodo de tiempo: Up to approximately 3 years

The time from the date of randomization to the investigator assessment of disease progression according to RECIST v1.1 or death from any cause

Up to approximately 3 years
cORR per RECIST v1.1 by investigator assessment
Periodo de tiempo: Up to approximately 3 years

The proportion of participants with confirmed CR or PR according to RECIST v1.1, as assessed by investigators

Up to approximately 3 years
Duration of response (DOR) per RECIST v1.1 by BICR
Periodo de tiempo: Up to approximately 3 years

The time from first documentation of objective response (CR or PR that is subsequently confirmed) to the first documentation of disease progression per RECIST v1.1 or death from any cause

Up to approximately 3 years
DOR per RECIST v1.1 by investigator assessment
Periodo de tiempo: Up to approximately 3 years

The time from first documentation of objective response (CR or PR that is subsequently confirmed) to the first documentation of disease progression per RECIST v1.1 or death from any cause

Up to approximately 3 years
Time to second progression or death (PFS2)
Periodo de tiempo: Up to approximately 3 years

The time from randomization to disease progression on the next-line of therapy, or death from any cause

Up to approximately 3 years
Incidence of adverse events (AEs)
Periodo de tiempo: Through 30 days after the last study treatment; approximately 1 year

Any untoward medical occurrence in a clinical investigational participant administered a medicinal product and which does not necessarily have a causal relationship with this treatment.

Through 30 days after the last study treatment; approximately 1 year
Trough concentration (Ctrough)
Periodo de tiempo: Approximately 4 months

PK parameter

Approximately 4 months
Change from baseline in European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30 (EORTC QLQC30) score
Periodo de tiempo: Through 30-37 days after the last study treatment; approximately 1 year

Change from baseline in European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) scores. Scale scores range from 0-100. For functioning and global health status/quality of life (QoL) scales, higher scores indicate better functioning or global health status/quality of life (QoL). For symptom scales, higher scores indicate greater symptom burden.

Through 30-37 days after the last study treatment; approximately 1 year
Time to meaningful change in EORTC QLQ30 score
Periodo de tiempo: Through 30-37 days after the last study treatment; approximately 1 year

The time from baseline to the first onset of a ≥10-point changes in European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) scores. Scale scores range from 0-100.

For functioning and global health status/QoL scales, higher scores indicate better functioning or global health status/QoL. For symptom scales, higher scores indicate greater symptom burden.

Through 30-37 days after the last study treatment; approximately 1 year

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Director de estudio: Pfizer CT.gov Call Center, Pfizer

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

24 de octubre de 2022

Finalización primaria (Estimado)

31 de diciembre de 2027

Finalización del estudio (Estimado)

3 de julio de 2030

Fechas de registro del estudio

Enviado por primera vez

14 de febrero de 2022

Primero enviado que cumplió con los criterios de control de calidad

14 de febrero de 2022

Publicado por primera vez (Actual)

24 de febrero de 2022

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

20 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

19 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

Sí

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir